Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relugolix CT in Endometriosis-associated Pelvic Pain
NCT07100782Phase 3Recruiting
- Sponsor
- University of Michigan
- Start
- Dec 2025
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of relugolix + estradiol + norethindrone in endometriosis, pelvic pain, sponsored by University of Michigan. Started Dec 2025; status: recruiting.
02
Drugs
relugolix + estradiol + norethindrone
03
Conditions
endometriosispelvic pain
Beyond the preview
Go deeper on NCT07100782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07100782.